Clinical trial
Remifentanil Only vs. Combination Group Midazolam + Meperidine During Elective Colonoscopy
NCT01693185 is registered in ClinicalTrials.gov with Konkuk University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Remifentanil Only vs. Combination Group Midazolam + Meperidine During Elective Colonoscopy
- Lead sponsor
- Konkuk University Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2012
- Completion date
- August 31, 2013
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diagnostic colonoscopy screening